Status:
RECRUITING
Study of the Involvement of Fatty Acids in Retinopathy of Prematurity: Relationship Between Retinopathy of Prematurity and the Rate of Expression of Transplacental Fatty Acid Receptors.
Lead Sponsor:
Centre Hospitalier Universitaire Dijon
Conditions:
Prematurity
Retinopathy
Eligibility:
All Genders
18+ years
Brief Summary
The development of the retinal vascular network is completed during the third trimester of pregnancy and and the first 15 days of life of the newborn. This late maturation can be problematic in cases ...
Eligibility Criteria
Inclusion
- Mothers giving birth to premature babies less than 29 weeks of amenorrhea (WA), after obtaining their non-opposition.
- Mothers giving birth at term between 39 and 41WA+6 days, after obtaining their non-opposition.
- ≥18 years
- Mothers not under legal protection
Exclusion
- Mothers giving birth between 29WA and 38WA+6 days
- Mothers in critical condition.
- Person not affiliated to national health insurance
- For full-term mothers: patient presenting or having presented a health condition that affected a previous pregnancy (vascular such as pregnant hypertension, preeclampsia; gestational diabetes; intrauterine growth retardation, maternal infection during pregnancy such as toxoplasmosis, cytomegalovirus, rubella, measles, chickenpox).
Key Trial Info
Start Date :
April 20 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2027
Estimated Enrollment :
135 Patients enrolled
Trial Details
Trial ID
NCT04819893
Start Date
April 20 2021
End Date
February 1 2027
Last Update
September 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Dijon Bourogne
Dijon, France, 21000